Working… Menu

A Phase 1 Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04941989
Recruitment Status : Not yet recruiting
First Posted : June 28, 2021
Last Update Posted : June 28, 2021
Information provided by (Responsible Party):
Heptares Therapeutics Limited

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : August 2022